Planet Briefing

First published · Last updated

Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study

Journal article published by Elsevier reporting a GLP-compliant systematic non-clinical safety evaluation of coenzyme I (NAD⁺), published 2026-11-01. The supplied excerpt contains only publisher and content-type information beyond the title.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
6/10
Geographic reach
1/10
Global importance
2/10
Impact magnitude
3/10
Positivity
6/10
Urgency
2/10

Why it matters

The study reports a systematic safety evaluation of NAD⁺ that is relevant to research and development around this compound.

Sources

Report an issue